13 patents
Utility
Perfusion System
25 May 23
A perfusion container for directly administering to patients a dose of an antineoplastic drug calculated according to a patient's parameter, wherein the first perfusion container comprises a solution of antineoplastic drug at a concentration and volume such that the amount of antineoplastic drug in the container is equal to the calculated dose for one patient but less than the calculated dose for a second patient, the calculated dose is provided to first patient within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container, further the first perfusion container is accompanied by a second top-up perfusion container comprising a solution of antineoplastic drug at a concentration and volume such that the calculated dose is provided within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container and the second top-up container to the second patient.
Subhas Balaram BHOWMICK, Prashant KANE, Samarth KUMAR, Kirti GANORKAR
Filed: 21 Nov 22
Utility
Perfusion system
17 Jan 23
A perfusion container for directly administering to patients a dose of an antineoplastic drug calculated according to a patient's parameter, wherein the first perfusion container comprises a solution of antineoplastic drug at a concentration and volume such that the amount of antineoplastic drug in the container is equal to the calculated dose for one patient but less than the calculated dose for a second patient, the calculated dose is provided to first patient within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container, further the first perfusion container is accompanied by a second top-up perfusion container comprising a solution of antineoplastic drug at a concentration and volume such that the calculated dose is provided within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container and the second top-up container to the second patient.
Subhas Balaram Bhowmick, Prashant Kane, Samarth Kumar, Kirti Ganorkar
Filed: 9 Feb 17
Utility
Fixed Dose Combination Drug for the Treatment of Malaria
25 Aug 22
A composition for treating malaria comprising Arterolane and Piperaquine is disclosed.
Altaf LAL, Amit NASA
Filed: 11 May 22
Utility
Plant cytochrome P450
26 Apr 22
This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.
Thilo Hans Winzer, Tracy Carol Walker, Ian Alexander Graham
Filed: 30 Oct 20
Utility
Parenteral dosage form of diltiazem
8 Feb 22
The present invention relates to a parenteral dosage form comprising a) a ready-to-infuse, stable aqueous solution comprising diltiazem or its pharmaceutically acceptable salt, pH adjusting agent to provide a pH in the range of 3 to 5 and ethanol, and b) an infusion container filled with said aqueous solution.
Samarth Kumar, Milan Natvarbhai Thakkar, Kandarp Maheshkumar Dave
Filed: 1 Dec 16
Utility
Dosage form of vinca alkaloid drug
13 Jul 21
The present invention relates to a dosage form comprising an aqueous solution of a vinca alkaloid drug or its pharmaceutically acceptable salt in a flexible infusion container, and a light protective secondary packaging containing the flexible infusion container, wherein the dosage form is ready-to-infuse and wherein the aqueous solution is stable at room temperature.
Subhas Balaram Bhowmick, Prashant Kane, Samarth Kumar, Ramaji Karshanbhai Varu, Nisarg Bipinchandra Mistry, Swapnil Ramesh Patil
Filed: 1 Aug 16
Utility
Plant Cytochrome P450
1 Apr 21
This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.
Thilo Hans Winzer, Tracy Carol Walker, Ian Alexander Graham
Filed: 30 Oct 20
Utility
Extended release multiparticulates of ranolazine
26 Jan 21
The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
Harinder Singh, Shavej Ahmad, Romi B. Singh
Filed: 24 Jan 18
Utility
Intravenous infusion dosage form
21 Dec 20
The present invention relates to an intravenous infusion dosage form of pemetrexed or its pharmaceutically acceptable salt, having long term stability.
Samarth Kumar, Prashant Kane, Subhas Balaram Bhowmick, Kirti Ganorkar, Nisarg Bipinchandra Mistry, Ramaji Karshanbhai Varu
Filed: 11 Feb 16
Utility
Plant cytochrome P450
23 Nov 20
This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.
Thilo Hans Winzer, Tracy Carol Walker, Ian Alexander Graham
Filed: 3 Feb 19
Utility
Perfusion System
18 Nov 20
A perfusion container for directly administering to patients a dose of an antineoplastic drug calculated according to a patient's parameter, wherein the first perfusion container comprises a solution of antineoplastic drug at a concentration and volume such that the amount of antineoplastic drug in the container is equal to the calculated dose for one patient but less than the calculated dose for a second patient, the calculated dose is provided to first patient within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container, further the first perfusion container is accompanied by a second top-up perfusion container comprising a solution of antineoplastic drug at a concentration and volume such that the calculated dose is provided within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container and the second top-up container to the second patient.
Subhas Balaram BHOWMICK, Prashant KANE, Samarth KUMAR, Kirti GANORKAR
Filed: 8 Feb 17
Utility
Parenteral Dosage Form of Diltiazem
5 Aug 20
The present invention relates to a parenteral dosage form comprising a) a ready-to-infuse, stable aqueous solution comprising diltiazem or its pharmaceutically acceptable salt, pH adjusting agent to provide a pH in the range of 3 to 5 and ethanol, and b) an infusion container filled with said aqueous solution.
Samarth KUMAR, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
Filed: 30 Nov 16
Utility
Pharmaceutical Composition of Nilotinib
27 May 20
A method of treating leukaemia comprising orally administering to a patient in need thereof reduced daily doses of nilotinib of 100 mg to 600 mg, wherein the nilotinib is administered in a dosage form having a composition comprising nilotinib butanedisulphonate (2:1) or nilotinib butanedisulphonate (1:1).
Harshal JAHAGIRDAR, Bhushan JADHAV, Amol KULKARNI, Shirish KULKARNI, Rajamannar THENNATI
Filed: 16 Mar 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first